Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 63Cardiovascular Diseases 3Neoplasms 2Stage II Prostate Adenocarcinoma 1Sarcopenia 1Prostatic Neoplasms, Castration-Resistant 1Prostatectomy 1Prostate Cancer With ≤10 Bone Metastases 1Prostate Cancer Metastatic Disease 1Prostate Cancer Metastatic 1Osteoporosis 1Oligometastatic Prostate Carcinoma 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Metastatic Neuroendocrine Prostate Cancer 1Metastatic Castration-resistant Prostate Cancer 1Metastatic Castration-Resistant Prostate Cancer 1Metabolic Syndrome 1Metabolic Diseases 1Eunuchism 1Diabetes Mellitus 1Dementia 1Cognitive Dysfunction 1Advanced Prostate Cancer 1

Interventions

Prednisone 1Gonadotropin-Releasing Hormone 1Exercise 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatectomy × Gonadotropin-Releasing Hormone × Genitourinary × Clear all
NCT04992026 2024-12-05

The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Completed
130 enrolled
Genitourinary

Prostatectomy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡